 |
인쇄하기
취소
|
Rotarix vaccine launched in Korea
GlaxoSmithKline (GSK) says it has launched Rotarix vaccine in Korea, representing the concrete step for GSK in providing a safe and effective vaccine to prevent rotavirus in this country.
Rotarix is an oral, two-dose, live attenuated vaccine developed from a single human strain designed to provide broad protection against multiple rotavirus strains and to provide early protection before the ...
Rotarix is an oral, two-dose, live attenuated vaccine developed from a single human strain designed to provide broad protection against multiple rotavirus strains and to provide early protection before the ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.